Paratransgenesis: Overview, Current Perspectives, and Future Research Needs for Malaria Control
Paratransgenesis: Overview, Current Perspectives, and Future Research Needs for Malaria Control
Tags: Malaria, Other invertebrates, Vector controlOziegbe, O., Okeke, C.C., Esho, D.O., Springer, Cham., 2025.
Malaria is an insect-borne disease (IBD) that is responsible for significant human mortality and morbidity globally. Several effective vector and parasite control strategies have been considered to control malaria. However, paratransgenesis is a strategy targeted towards parasite development disruption rather than vector elimination which can potentially address insecticide resistance in mosquitoes. Genetically modified symbionts such as bacteria, fungi, or viruses secrete anti-plasmodial effector molecules that kill or inhibit the development of Plasmodium species without affecting the vector or the microorganism. Various anti-plasmodial effector molecules have been identified such as scorpin, a peptide from scorpion venom that acts by lysing the parasite, enolase- plasminogen interaction peptide (EPIP) which acts by inhibiting midgut invasion, A protein kinase (Akt) that acts by activating innate immune responses, and salivary gland and midgut peptide 1 (SMI) that acts by preventing binding to the parasite surface proteins. For this strategy to be successful, the selected symbiotic microorganism should be easy to culture and genetically manipulate, stable, as well as capable of producing effector molecules with anti-plasmodial activity while colonizing a wide range of the host species. Paratransgenesis presents a promising future for malaria control globally. However, its efficacy and safety as a malaria control strategy should be experimented with in large outdoor settings with more elaborate and collaborative studies carried out to sustain the approach in malaria-endemic countries.
